2. A newly created, US-based pharmaceutical firm, Vortex, has the market strategy of creating cost-effective generic medications. They spent $75 million in salaries and grants for pharmaceutical researchers to produce potential patents for new generic drugs. Furthermore, once their product line was selected, they invested $625 million in building a production and quality assurance lab. Moork, a Swedish peer firm, uses IFRS to prepare their financial statements.

Make the adjusting entry or entries needed to be able to directly compare Vortex to Moork.